KindlyMD Lands Game-Changing Funding to Supercharge Bitcoin Adoption Strategy
Bitcoin just got a heavyweight backer in healthcare. KindlyMD—the telehealth platform merging medicine with crypto—just secured a major funding round to double down on its BTC strategy.
Why it matters: Traditional finance keeps treating crypto like a sideshow. Meanwhile, forward-thinking companies are building real-world use cases that could make banks obsolete.
The punchline: While Wall Street debates ETF fees, KindlyMD’s move proves institutional money is already flowing into operational bitcoin plays—no SEC approval required.

New Funding and Merger Process
So far, KindlyMD has amassed approximately $563 million in PIPE (Private Investment in Public Equity) funding. When convertible notes are included, this amount reaches $763 million. The latest investment was completed at a valuation of $5 per share and was finalized in less than 72 hours. The company plans to use the funds for both bitcoin purchases and working capital needs.
David Bailey, the founder and CEO of Nakamoto Holdings, highlighted the strong interest from investors and shared that the funding round was completed very quickly.
“Investor demand is incredibly strong for Nakamoto. This additional funding was gathered in less than 72 hours. We continue our strategy of raising as much capital as possible to acquire as many Bitcoins as possible.”
Investments and Strategic Goals
Company officials emphasized that the funds will not only be used for acquiring Bitcoin but also for operational activities. This new investment will close concurrently with the merger between KindlyMD and Nakamoto Holdings. The merger is expected to be completed in the third quarter of 2025, concluding with the review by the U.S. Securities and Exchange Commission (SEC) and shareholder notification.
Tim Pickett, CEO of KindlyMD, emphasized the merger’s contribution to business processes.
“We are pleased to reach this significant milestone in the merger process. We aim to leverage both Bitcoin’s market power and its real-world application opportunities to benefit our company and plan to generate long-term value for our investors.”
KindlyMD’s Operational Sphere and Market Position
KindlyMD provides personalized treatment and data-driven services in alternative medicine, focusing particularly on reducing opioid use while utilizing health insurance programs (Medicare, Medicaid, and private insurances). This approach offers KindlyMD a unique position in both the healthcare and financial sectors.
Nakamoto Holdings is pioneering Bitcoin-based financial structures. Company President David Bailey said,
“Our goal is to position Bitcoin at the heart of global capital markets, in a compliant and transparent manner. By partnering with Anchorage Digital, we aim to maintain the highest security standards and provide sustainable value to our shareholders.”
On May 20, KindlyMD received approval from its shareholders regarding the merger with Nakamoto Holdings, marking a significant step towards becoming a large publicly traded Bitcoin treasury company. Upon completion of the merger, Bitcoin will become a significant part of KindlyMD’s corporate balance sheet, directing the company’s strategic focus on digital assets.
These funding and merger steps between KindlyMD and Nakamoto Holdings indicate the growing importance of digital assets at an institutional level. The positioning of Bitcoin at the center of their capital and technological infrastructure signals a new era for both investors and capital markets. Positioned at the intersection of healthcare and finance, KindlyMD showcases how corporate structures can undertake innovative initiatives through alternative financial strategies. The successful accumulation and swift completion of the funding process clearly reflect the interest and anticipation surrounding the topic.
You can follow our news on Telegram, Facebook, Twitter & Coinmarketcap Disclaimer: The information contained in this article does not constitute investment advice. Investors should be aware that cryptocurrencies carry high volatility and therefore risk, and should conduct their own research.